Eli Lilly Boosts Indiana Investment to $9B for Weight Loss Drug Expansion
TL;DR Summary
Eli Lilly is investing $5.3 billion in the US to tap into the lucrative $100 billion weight loss drug market.
- Eli Lilly chases $100bn weight loss drug market with $5.3bn US investment Financial Times
- Lilly increases investment to Lebanon manufacturing site to $9B WTHR
- Lilly's huge expansion plan took place at record speed to reduce bottlenecks for Mounjaro, Zepbound – Indianapolis Business Journal Indianapolis Business Journal
- Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply CNBC
- Lilly increases Indiana investment to $9 billion for weight loss drugs USA TODAY
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
0 min
vs 1 min read
Condensed
81%
107 → 20 words
Want the full story? Read the original article
Read on Financial Times